» Articles » PMID: 28938069

Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y Receptor

Overview
Journal J Med Chem
Specialty Chemistry
Date 2017 Sep 23
PMID 28938069
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

A homology model of the nucleotide-activated P2YR was created based on the X-ray structures of the P2Y receptor. Docking studies were performed, and receptor mutants were created to probe the identified binding interactions. Mutation of residues predicted to interact with the ribose (Arg110) and the phosphates of the nucleotide agonists (Arg265, Arg292) or that contribute indirectly to binding (Tyr288) abolished activity. The Y114F, R194A, and F261A mutations led to inactivity of diadenosine tetraphosphate and to a reduced response of UTP. Significant reduction in agonist potency was observed for all other receptor mutants (Phe111, His184, Ser193, Phe261, Tyr268, Tyr269) predicted to be involved in agonist recognition. An ionic lock between Asp185 and Arg292 that is probably involved in receptor activation interacts with the phosphate groups. The antagonist AR-C118925 and anthraquinones likely bind to the orthosteric site. The updated homology models will be useful for virtual screening and drug design.

Citing Articles

Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y Receptor.

Knight R, Kilpatrick L, Hill S, Stocks M ACS Med Chem Lett. 2024; 15(7):1127-1135.

PMID: 39015271 PMC: 11247638. DOI: 10.1021/acsmedchemlett.4c00211.


Double-modified, thio and methylene ATP analogue facilitates wound healing in vitro and in vivo.

Pawlowska R, Radzikowska-Cieciura E, Jafari S, Fastyn J, Korkus E, Gendaszewska-Darmach E Sci Rep. 2024; 14(1):13148.

PMID: 38849425 PMC: 11161507. DOI: 10.1038/s41598-024-63759-5.


How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.

Dales M, Drummond R, Kennedy C Purinergic Signal. 2024; .

PMID: 38740733 DOI: 10.1007/s11302-024-10016-z.


Machine learning-aided search for ligands of P2Y and other P2Y receptors.

Puhl A, Lewicki S, Gao Z, Pramanik A, Makarov V, Ekins S Purinergic Signal. 2024; 20(6):617-627.

PMID: 38526670 PMC: 11554998. DOI: 10.1007/s11302-024-10003-4.


Pharmacological characterization of P2Y receptor subtypes - an update.

von Kugelgen I Purinergic Signal. 2023; 20(2):99-108.

PMID: 37697211 PMC: 10997570. DOI: 10.1007/s11302-023-09963-w.